4th Quarter - Report

STRYKER CORPORATION for STRYKER CORPORATION

Firm
Client
Income
—
Expenses
$40,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act

LobbyistCovered position, as disclosed
PAGE KRANBUHL Senate HELP Subcommittee staff

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Funding for the FDA Center for Devices and Radiological Health

LobbyistCovered position, as disclosed
PAGE KRANBUHL Senate HELP Subcommittee staff

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

S. 232, Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices

LobbyistCovered position, as disclosed
PAGE KRANBUHL Senate HELP Subcommittee staff

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 232 (113th), H.R. 523 (113th)

Medicare/Medicaid MMM

Implementation of Public Law 111-148: The Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Medicare Reimbursement for joint replacement procedures

LobbyistCovered position, as disclosed
PAGE KRANBUHL Senate HELP Subcommittee staff
ERIC RUGO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.